IRCT20240131060872N1招募中3 期
Comparison of morning vs. evening administration of Amlodipine/Valsartan in hypertensive patients at Loghman hospital
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 75 years（—）
- 性别
- All
入选标准
- •Age range between 35-75
- •Absence of underlying disease such as no renal diseases, no diabetes mellitus, and no cardiovascular diseases
- •No previous history of hypertension treatment
- •Consent to enter the study
排除标准
- •Having renal diseases
- •Having diabetes Mellitus
- •Having cardiovascular diseases including ischemic, non-ischemic, and heart failure
研究者
相似试验
进行中（未招募）
不适用
The influence of morning versus evening administration on tamoxifen pharmacokineticsMedDRA version: 14.1Level: LLTClassification code 10070575Term: Estrogen receptor positive breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2012-000406-29-NL18
进行中（未招募）
不适用
Effects of morning vs evening dosing on the pharmacokinetics and pharmacodynamics of sunitinib.Renal Cell Cancer, GIST, pancreatic neuroendocrine tumorMedDRA version: 14.1Level: LLTClassification code 10067518Term: Pancreatic neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10023400Term: Kidney cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10055008Term: Gastric sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-000425-45-NL18
已完成
不适用
Comparison of morning vs evening dosing of the latanoprost/timolol maleate fixed combination (Xalacom) on intraocular pressure control in primary open angle glaucoma. -Pilot Studyprimary open angle glaucomaJPRN-UMIN000011275Department of Ophthalmology, Kanazawa University40
已完成
1 期
The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of EmpagliflozinPharmacokineticsPharmacodynamicsDiabetes MellitusNCT03895229Ain Shams University16
已完成
不适用
Treatment in morning versus evening studyTopic: Primary Care, Cardiovascular diseaseSubtopic: Other Primary Care, Cardiovascular (all Subtopics)Disease: All Diseases, OtherCirculatory SystemISRCTN18157641HS Tayside (UK)21,104